Open AccessThe first experience of implantation of the transcatheter aortal valve prosthesis “MedLab-KT”
Author(s) -
A.V. Bogachev-Prokofiev,
Ravil Sharifulin,
Д. Д. Зубарев,
А. М. Караськов
Publication year - 2018
Publication title -
rossijskij kardiologičeskij žurnal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.141
H-Index - 14
eISSN - 2618-7620
pISSN - 1560-4071
DOI - 10.15829/1560-4071-2018-11-50-56
Subject(s) - medicine , prosthesis , regurgitation (circulation) , myocardial infarction , surgery , valve replacement , aortic valve , cardiology , stenosis
Aim. Transcatheter aortic valve replacement in patients with high and extremely high risk has become a routine procedure in many cardiac surgery clinics. Until recently, there were no transcatheter prostheses produced within Russia. This article analyzes the results of applying the first domestic transcatheter aortic valve prosthesis MedLabKT. Material and methods. In the period from June 2018 to October 2018, 7 operations of transcatheter aortic valve replacement were made using the MedLabKT prosthesis. In all cases, implantation was performed by transapical access. Results. We noted one death. In all cases, paraprosthetic regurgitation was not registrated or was not significant. There are no cases of dislocation of the prosthesis. There were no complications associated with access. In one case, implantation was complicated by myocardial infarction. Conclusion. The first experience of implantation demonstrated the efficacy and safety of using the MedLabLT prosthesis for transcatheter aortic valve replacement. The analysis of longterm results is required.